Publications found:
73,128
Sort by:
Hypertrophic Cardiomyopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypertrophic Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertrophic Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
88 pages
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2020
US$ 2,000.00
... -Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
83 pages
Ventricular Tachycardia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ventricular Tachycardia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ventricular Tachycardia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
53 pages
Kidney Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Kidney Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
172 pages
Chikungunya Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
126 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
552 pages
Adenosine Receptor A3 - Pipeline Review, H1 2020
US$ 3,500.00
Adenosine Receptor A3 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Adenosine Receptor A3 - Pipeline Review, H1 2020'; Adenosine Receptor A3 (ADORA3) pipeline Target...
April 2020
85 pages
Cathepsin B - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin B - Pipeline Review, H1 2020 SUMMARY Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molec...
April 2020
32 pages
Cathepsin L1 - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin L1 - Pipeline Review, H1 2020 SUMMARY Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like f...
April 2020
33 pages
Cathepsin S - Pipeline Review, H1 2020
US$ 3,500.00
Cathepsin S - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Cathepsin S - Pipeline Review, H1 2020'; Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes clo...
April 2020
33 pages
Coagulation Factor XI - Pipeline Review, H1 2020
US$ 3,500.00
Coagulation Factor XI - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Coagulation Factor XI - Pipeline Review, H1 2020'; Coagulation Factor XI (Plasma Thromboplastin A...
April 2020
69 pages
Collagenase 3 - Pipeline Review, H1 2020
US$ 3,500.00
Collagenase 3 - Pipeline Review, H1 2020 SUMMARY Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 mol...
April 2020
60 pages
Estrogen Receptor Beta - Pipeline Review, H1 2020
US$ 3,500.00
Estrogen Receptor Beta - Pipeline Review, H1 2020 SUMMARY Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) pipeline Target constitutes close to 20 m...
April 2020
78 pages
Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020
US$ 3,500.00
Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020 SUMMARY Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 16 molecules. Out of w...
April 2020
70 pages
Gamma Secretase - Pipeline Review, H1 2020
US$ 3,500.00
Gamma Secretase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Gamma Secretase (EC 3.4.23.) - Pipeline Review, H1 2020'; Gamma Secretase (EC 3.4.23.) pipeline Target...
April 2020
77 pages
Growth/Differentiation Factor 8 - Pipeline Review, H1 2020
US$ 3,500.00
Growth/Differentiation Factor 8 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'GrowthDifferentiation Factor 8 - Pipeline Review, H1 2020'; Growth/Differentiation Fact...
April 2020
79 pages
Hepatocyte Growth Factor - Pipeline Review, H1 2020
US$ 3,500.00
Hepatocyte Growth Factor - Pipeline Review, H1 2020 SUMMARY Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 15 molecules. The latest report H...
April 2020
80 pages
Histone Deacetylase 1 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 1 - Pipeline Review, H1 2020 SUMMARY Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 is an enzyme encoded by the HDAC1 gene. The protein encoded by this gene...
April 2020
167 pages
Histone Deacetylase 2 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 2 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Histone Deacetylase 2 - Pipeline Review, H1 2020'; Histone Deacetylase 2 (Transcriptional Regulat...
April 2020
145 pages
Histone Deacetylase 3 - Pipeline Review, H1 2020
US$ 3,500.00
Histone Deacetylase 3 - Pipeline Review, H1 2020 SUMMARY Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Histone deacetylase 3 is an enzyme encoded by the HDAC3 gene. Histone deac...
April 2020
105 pages
Matrix Metalloproteinase 9 - Pipeline Review, H1 2020
US$ 3,500.00
Matrix Metalloproteinase 9 - Pipeline Review, H1 2020 SUMMARY Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Matrix metallopep...
April 2020
53 pages
Melanocortin Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Melanocortin Receptor 4 - Pipeline Review, H1 2020 SUMMARY Melanocortin Receptor 4 (MC4R) - Melanocortin 4 receptor (MC4R) is a G protein-coupled receptor involved in the hypothalamic leptin-melanoc...
April 2020
83 pages
Nociceptin Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Nociceptin Receptor - Pipeline Review, H1 2020 SUMMARY Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline Target constitutes close to 16 molecules....
April 2020
52 pages
Orexin Receptor Type 1 - Pipeline Review, H1 2020
US$ 3,500.00
Orexin Receptor Type 1 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Orexin Receptor Type 1 - Pipeline Review, H1 2020'; Orexin Receptor Type 1 (Hypocretin Receptor...
April 2020
80 pages
Orexin Receptor Type 2 - Pipeline Review, H1 2020
US$ 3,500.00
Orexin Receptor Type 2 - Pipeline Review, H1 2020 SUMMARY Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) pipeline Target constitutes close to 9 molecules. Out of which approximately 8...
April 2020
83 pages
Placenta Growth Factor - Pipeline Review, H1 2020
US$ 3,500.00
Placenta Growth Factor - Pipeline Review, H1 2020 SUMMARY Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) pipeline Target constitutes close to 21 molecules. The la...
April 2020
88 pages
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020
US$ 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Retinoic acid receptor al...
April 2020
76 pages
Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020
US$ 3,500.00
Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020'; Retinoic Acid Receptor Gamma (RA...
April 2020
82 pages
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H1 2020
US$ 3,500.00
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H1 2020 SUMMARY Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) pipeline Target con...
April 2020
72 pages
Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020 SUMMARY Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) pipeline Target constitutes close to 10 molecules. Out of w...
April 2020
55 pages
Asia Pacific mHealth Market By Type (Services and Devices) By Services (Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others) By Devices (BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others) By Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers and Content Players) By Application (Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
US$ 1,500.00
The Asia Pacific mHealth Market would witness market growth of 32.7% CAGR during the forecast period (2020-2026). Emerging mobile health promotion technologies (mHealth) have revolutionized the health...
April 2020
158 pages
Europe mHealth Market By Type (Services and Devices) By Services (Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others) By Devices (BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others) By Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers and Content Players) By Application (Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
US$ 1,500.00
The Europe mHealth Market would witness market growth of 31.1% CAGR during the forecast period (2020-2026). The prevalence of chronic diseases has risen in Europe over the last decades in line with th...
April 2020
156 pages
Global mHealth Market By Type (Services and Devices) By Services (Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others) By Devices (BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others) By Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers and Content Players) By Application (Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026
US$ 3,600.00
The Global mHealth Market size is expected to reach $206.1 billion by 2026, rising at a market growth of 31.6% CAGR during the forecast period. Mobile health (mHealth) refers to the practice of mobile...
April 2020
377 pages
LAMEA mHealth Market By Type (Services and Devices) By Services (Monitoring services, Diagnosis services, Healthcare Systems Strengthening Services and Others) By Devices (BP Monitors, Cardiac Monitors, Pulse Oximetry, Blood Glucose Meters, Apnea & Sleep Monitors, Neurological Monitors, Wearable Fitness Sensor Device & Heart Rate Meters and Others) By Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers and Content Players) By Application (Cardiovascular Diseases, Diabetes, Respiratory, Neurology and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
US$ 1,500.00
The Latin America, Middle East and Africa mHealth Market would witness market growth of 32.4% CAGR during the forecast period (2020-2026). mHealth apps are expected to see a lucrative growth rate over...
April 2020
157 pages
